Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clear-Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03203473
What this trial is testing

Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

Who this might be right for
Renal Cancer
Toni Choueiri, MD 85
Not applicableUnknownNCT04609293
What this trial is testing

Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking University First Hospital 30
Not applicableNo Longer AvailableNCT03896815
What this trial is testing

Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

Incyte Corporation
Testing effectiveness (Phase 2)Looking for participantsNCT07615348
What this trial is testing

CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
Jinling Hospital, China 75
Testing effectiveness (Phase 2)Ended earlyNCT00100685
What this trial is testing

Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell CarcinomaMetastases
Abbott 48
Testing effectiveness (Phase 2)Study completedNCT00003968
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 35
Not applicableEnded earlyNCT02131376
What this trial is testing

Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy

Who this might be right for
Renal Cell Carcinoma
Indiana University 26
Testing effectiveness (Phase 2)Study completedNCT00494091
What this trial is testing

Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma
Pfizer 82
Very early researchActive Not RecruitingNCT02210117
What this trial is testing

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 104
Testing effectiveness (Phase 2)Study completedNCT00057889
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00421512
What this trial is testing

A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients

Who this might be right for
Metastatic Renal Cell CarcinomaKidney Cancer
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT01158534
What this trial is testing

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Who this might be right for
Renal Cell CancerStage IV Renal Cell Cancer
Case Comprehensive Cancer Center 17
Not applicableStudy completedNCT02645409
What this trial is testing

Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Chandru Sundaram 14
Early research (Phase 1)UnknownNCT01914263
What this trial is testing

Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaLung Cancer
Alliancells-PuRui Biocience Co., Ltd. 40
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT00630409
What this trial is testing

Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
University of Pittsburgh 5
Not applicableLooking for participantsNCT06076538
What this trial is testing

PET/MR for Characterization of Renal Masses (RMs)

Who this might be right for
Renal TumorRenal Cell CarcinomaRenal Tumor, Benign
University of Texas Southwestern Medical Center 97
Testing effectiveness (Phase 2)WithdrawnNCT00040989
What this trial is testing

BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer

Who this might be right for
Stage IV Renal Cell CancerRecurrent Renal Cell Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07551349
What this trial is testing

Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Beijing Biotech 36
Not applicableUnknownNCT04503148
What this trial is testing

Anesthesia and Cancer Study: Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Seoul National University Hospital 562
Next Page